The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvingtrans Regulatory News (AVG)

Share Price Information for Avingtrans (AVG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 425.00
Bid: 420.00
Ask: 430.00
Change: 0.00 (0.00%)
Spread: 10.00 (2.381%)
Open: 425.00
High: 425.00
Low: 425.00
Prev. Close: 425.00
AVG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update and Notice of Results

7 Jul 2022 07:00

RNS Number : 5778R
Avingtrans PLC
07 July 2022
 

7 July 2022

Avingtrans Plc

("Avingtrans", the "Company", or the "Group")

Trading Update and Notice of Results

Avingtrans PLC (AIM: AVG), which designs, manufactures and supplies critical components, modules, systems and associated services to the energy, medical and industrial sectors, announces a trading update in respect of the financial year ended 31 May 2022.

The Board is pleased to report that the results for the year ended 31 May 2022 are expected to be in line with market expectations. The Group's year end net cash position was strong, standing at in excess of £16 million (excluding IFRS 16), following investments in the period in Magnetica, Adaptix and Transkem, compared to £23 million as at 31 May 2021. The Group's order and prospect pipeline also remains strong.

Hayward Tyler, Inc. has secured a contract extension for the continued development of next generation molten salt pumps, under the Advanced Reactor Demonstration Program, valued at US $1.1m. This recent contract extends the program value beyond $2.5 million since June 2021. In addition to the contract extension, Hayward Tyler, Inc. became the first US company to update its ASME "N" Certifications to include Section III, Division 5 equipment. This section of the code allows for design, manufacture, and inspection of pumps and process equipment for advanced, high temperature nuclear reactors.

Avingtrans partner company, Adaptix, has filed its 510(k) premarket notification with the US FDA - allowing the company to begin marketing its Point-of-Care 3D orthopedic system in the United States. Adaptix has developed novel technologies that allow affordable, low-dose 3D imaging at the Point-of-Care using Digital Tomosynthesis (DT), to provider quicker, more accurate diagnosis possibilities. This is a significant milestone for Adaptix and trailblazes the path for Magnetica.

The Company is also pleased to have received an award for 'Transaction of the Year', in relation to the disposal of Peter Brotherhood in 2021, at the annual Small Cap Awards ceremony 2022. The Company has been judged amongst the best companies and participants in the small and micro-cap community across thirteen categories recognising outstanding achievement. The award is welcome recognition of the Group's successful PIE strategy, which aims to maximise shareholder value over the long term.

Notice of Results

Avingtrans will publish its results for the twelve months ended 31 May 2022 on 28 September 2022. 

The management team will be hosting a presentation for analysts on the day of results - for more information please contact Zach Cohen at IFC Advisory on zach.cohen@investor-focus.co.uk

Steve McQuillan, CEO of Avingtrans, commented:

"We are very pleased with the performance of the Group, overcoming many challenges and working tirelessly to report results for the year ended 31 May 2022 in line with market expectations. The Company has entered the new financial year with continued momentum, with strategic progress continuing and a robust pipeline of opportunites setting the foundations for solid growth for the coming year."

Enquiries:

Avingtrans plc

01354 692391

Roger McDowell, Chairman

Steve McQuillan, Chief Executive Officer

Stephen King, Chief Financial Officer

 

Singer Capital Markets (Nominated Adviser and Broker)

02074 963000

Shaun Dobson

Alex Bond

Oliver Platts

Rachel Hayes

 

IFC Advisory (Financial PR)

020 3934 6630

Graham Herring

Tim Metcalfe

Zach Cohen

 

 

About Avingtrans plc: 

Avingtrans designs, manufactures and supplies original equipment, systems and associated aftermarket services to the energy, medical and industrial markets worldwide. 

Business units

Hayward Tyler - Luton & East Kilbride, UK and USA, China and India

Specialises in the design, manufacture and servicing of performance-critical motors and pumps for challenging environments.

Energy Steel, Inc - Rochester Hills, Michigan, USA

Energy Steel, part of the Engineered Pumps and Motors Division of Avingtrans plc, has been serving the nuclear power industry since 1982 with capabilities in equipment fabrication, material supply, precision machining, engineering, and repair services. Through strategic OEM partnerships, it also provides solutions for obsolete nuclear components and support for the most complex projects. 

Stainless Metalcraft Ltd - Chatteris, UK and Chengdu, China

Provider of safety-critical equipment for the energy, medical, science and research communities, worldwide, specialising in precision pressure and vacuum vessels and associated fabrications, sub-assemblies and systems.

Booth Industries - Bolton, UK

Designs, manufactures, installs and services doors and walls which can be tailored to be: blast &explosion proof; fireproof; acoustically shielded; high security/safety; or combinations of the above

Ormandy Group, Bradford, UK

Design, manufacturers and servicing of off-site plant, heat exchangers and other HVAC (heating, ventilation and air conditioning) products

Composite Products Ltd - Buckingham, UK

Centre for composite technology, parts and assemblies, serving customers in industrial markets.

Magnetica Ltd - Brisbane, Australia

Magnetica Limited specialises in the development of next generation MRI technologies, including dedicated extremity MRI systems and MRI system components. Magnetica has successfully built and tested a compact, integrated 3 Tesla orthopaedic MRI system, demonstrating clinical-quality imaging. Commercialisation of this system (and others) is on-going. Magnetica's structure now includes two other business units:

Scientific Magnetics - Abingdon, UK

Designs and manufactures superconducting magnet systems and associated cryogenics for a variety of markets including MRI and provides services for Nuclear Magnetic Resonance instruments. 

Tecmag Inc, Houston, USA

Designs, manufactures and installs instrumentation, including consoles, system upgrades, and probes, mainly for Magnetic Resonance Imaging (MRI) and Nuclear Magnetic Resonance (NMR) systems.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTRFMATMTBMBRT
Date   Source Headline
29th Jun 20217:00 amRNSMetalcraft training school planning go-ahead
2nd Jun 20217:00 amRNSBooth Industries Reincorporates
1st Jun 20217:00 amRNSMetalcraft secures Phase 2 Sellafield box contract
29th Apr 20214:30 pmRNSDirector Shareholdings, Exercise of Options & TVR
13th Apr 20217:00 amRNSExercise of Options and Total Voting Rights
12th Apr 20211:16 pmRNSHolding(s) in Company
9th Apr 20219:59 amRNSHolding(s) in Company
1st Apr 20217:00 amRNSDirector Shareholdings, Exercise of Options & TVR
12th Mar 20217:00 amRNSDisposal of Peter Brotherhood Limited
10th Feb 20217:00 amRNSInterim Results
29th Jan 20217:00 amRNSCompletion of Acquisition
26th Jan 20212:11 pmRNSHolding(s) in Company
26th Jan 202110:15 amRNSHolding(s) in Company
21st Jan 20217:00 amRNSBooth secures £2.9m contract extension
13th Jan 20217:00 amRNSTrading Update and Notice of Results
6th Jan 20212:40 pmRNSHolding(s) in Company
5th Jan 20217:00 amRNSAcquisition of Majority Stake in new Medtech JV
16th Dec 202011:51 amRNSExercise of Options and Total Voting Rights
14th Dec 20201:16 pmRNSHolding(s) in Company
24th Nov 20202:51 pmRNSEmployee & PDMR Share Incentive Awards
18th Nov 202012:54 pmRNSResult of AGM
4th Nov 20207:00 amRNSExercise of Options, PDMR Dealings and TVR
3rd Nov 202012:06 pmRNSHolding(s) in Company
28th Oct 20204:44 pmRNSHolding(s) in Company
26th Oct 20201:31 pmRNSHolding(s) in Company
23rd Oct 20203:30 pmRNSHolding(s) in Company
23rd Oct 20207:55 amRNSCompletion of Placing in Avingtrans plc
22nd Oct 20206:09 pmRNSClose of Bookbuild
22nd Oct 20204:35 pmRNSProposed Placing in Avingtrans plc
16th Oct 20207:00 amRNSNotice of AGM
7th Oct 20207:00 amRNSExercise of Options & TVR
6th Oct 20209:27 amRNSHolding(s) in Company
30th Sep 20207:00 amRNSPreliminary Results for the year ended 31 May 2020
29th Sep 20207:00 amRNSBooth Industries secures £36m HS2 contract
15th Sep 20207:00 amRNSNotice of Results and Q1 Trading Update
1st Sep 20207:00 amRNSPDMR Exercise of Options and Total Voting Rights
7th Jul 20207:00 amRNSTrading Update and Contract Wins
9th Apr 20207:00 amRNSCovid-19 Update
10th Mar 20202:14 pmRNSHolding(s) in Company
26th Feb 20207:00 amRNSInterim Results
23rd Jan 20207:00 amRNSTrading Update and Notice of Results
17th Jan 20208:00 amRNSHolding(s) in Company
13th Jan 20201:37 pmRNSExercise of Options and Total Voting Rights
13th Jan 20207:00 amRNSHayward Tyler Awarded £2m Solar Contract in Dubai
23rd Dec 20191:57 pmRNSHolding(s) in Company
20th Dec 20197:00 amRNSExercise of Options and Total Voting Rights
18th Dec 20197:00 amRNSShare Incentive Awards, Issue of Equity and TVR
14th Nov 201911:15 amRNSResult of AGM and Change of Director
8th Nov 20197:00 amRNSPDMR Shareholding
1st Nov 20193:37 pmRNSDirector Shareholdings, Exercise of Options & TVR

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.